Cambridge Nutritional Sciences plc

Equities

ODX

GB00B1VCP282

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. Other stock markets 11:35:12 2024-05-21 am EDT			5-day change	1st Jan Change
4 ^GBX	0.00%		+2.56%	+66.67%

Apr. 22	Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named	MT
Apr. 22	Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024	CI

Bill Rhodes to Step Down as Non-Executive Director from Omega Diagnostics Group PLC

January 19, 2022 at 02:00 am EST

Omega Diagnostics Group PLC also announced that Bill Rhodes, Non-Executive Director, has notified the Board that he will also step down from his role at the end of February 2022. The Company will begin the process of seeking suitable Non-Executive Director candidates.

Latest news about Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named	Apr. 22	MT
Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024	Apr. 22	CI
Cambridge Nutritional Sciences plc Announces Board Changes	Apr. 22	CI
Cambridge Nutritional Sciences hires first operations chief	Jan. 29	AN
Cambridge Nutritional Sciences plc Announces Appointment of James Cooper as Operations Director	Jan. 29	CI
Cambridge Nutritional Sciences develops education programme	Dec. 04	AN
Transcript : Cambridge Nutritional Sciences plc, H1 2024 Earnings Call, Nov 23, 2023	Nov. 23
Cambridge Nutrition loss narrows as revenue surges; outlook optimistic	Nov. 23	AN
Earnings Flash (CNSL.L) CAMBRIDGE NUTRITIONAL SCIENCES Reports H1 Revenue GBP4.9M	Nov. 23	MT
Earnings Flash (CNSL.L) CAMBRIDGE NUTRITIONAL SCIENCES Reports Fiscal H1 Loss GBX-0.30	Nov. 23	MT
Cambridge Nutritional Sciences plc Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 23	CI
Cambridge Nutritional Sciences plc Provides Revenue Guidance for the Fiscal Year 2024	Nov. 23	CI
Cambridge Nutritional Sciences completes name change	23-09-15	AN
Omega Diagnostics Group Officially Changes Name to Cambridge Nutritional Sciences	23-09-15	MT
Omega Diagnostics Group PLC has Changed its Name to Cambridge Nutritional Sciences plc	23-09-15	CI
FTSE 100 Finishes 0.16% Lower as Mood Stays Cautious	23-09-06	DJ
Solid State sees strong orders in security & defence	23-09-06	AN
Harbour Energy Seen as Performing Well Operationally	23-09-06	DJ
Sterling Could Rise Against Euro, Looks Vulnerable Versus Dollar	23-09-06	DJ
Omega Diagnostics Group Abandons Share Consolidation Plan; Stock Jumps 14%	23-09-01	MT
Omega Diagnostics Group Directors Propose Name Change	23-08-31	MT
FTSE 100 Closes Higher, Breaking Seven-Day Losing Streak	23-08-22	DJ
Omega Diagnostics finance director steps down with immediate effect	23-08-22	AN
FTSE 100 Rises in Early Trade; Miners Gain	23-08-22	DJ
Omega Diagnostics Group Finance Director Quits; Proposes Name Change	23-08-22	MT

Chart Cambridge Nutritional Sciences plc

Duration

Period

Chart Cambridge Nutritional Sciences plc

More charts

Company Profile

Cambridge Nutritional Sciences plc is a United Kingdom-based specialist medical diagnostics company. The Company develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The Company serves healthcare professionals and the consumer directly with a focus on health and nutrition products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-06-05 - Integrative and Personalised Medicine Conference

More about the company

Income Statement Evolution

More financial data

Ratings for Cambridge Nutritional Sciences plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
CAMBRIDGE NUTRITIONAL SCIENCES PLC	+66.67%	12.09M
BIOMÉRIEUX	-6.26%	12.23B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-3.93%	8.17B
DIASORIN S.P.A.	+7.10%	5.78B
LANTHEUS HOLDINGS, INC.	+30.16%	5.74B
AUTOBIO DIAGNOSTICS CO., LTD.	-7.47%	4.24B
10X GENOMICS, INC.	-57.20%	2.97B
ANDON HEALTH CO., LTD.	+12.56%	2.73B
VITROLIFE AB	-4.67%	2.38B
MYRIAD GENETICS, INC.	+27.38%	2.26B

Diagnostic & Testing Substances